There are many reports of how CBD isolates have helped a lot of people get relief from different symptoms, including pains, stress, inflammation, nausea, etc. But are you aware of the potential of this form of cannabidiol (CBD)? Probably NO! Many people tend to focus more on the full-spectrum CBD due to the entourage effects
CBD
If you consider all that has been written about Cannabidiol (CBD), you would find that very little attention is paid to CBD isolates. Many are blown away by the benefits of full-spectrum CBD and the talks of the entourage effects that they often pay no mind to the isolates. But that in my opinion is
Hemp-derived CBD giant Charlotte’s Web Holdings is positioning itself to enter THC and marijuana markets. The Boulder, Colorado, company says it has signed a five-year, $8 million purchase agreement option with a marijuana company started by its founders, Stanley Brothers USA Holdings Inc. The deal allows Charlotte’s Web to take over the marijuana business after
Minor cannabinoids have been gathering interest among growers and extractors over the past year, with research on CBG, CBN, CBC and THC-V showing unique health benefits for consumers. But are consumers even aware of these molecules and is there demand in the marketplace? And are there genetics available that can yield enough of these minor
This story first appeared at Marijuana Business Daily. The development of new genetic-editing technology offers cannabis companies a cost-effective way to make specific changes to marijuana and hemp plants – such as more disease resistance – without creating a genetically modified organism. The technology, known as Crispr-Cas9, will allow the cannabis industry to build new,
High-CBD plants inherit approximately 90% of their genes from marijuana, according to a new cannabis genomics study by the University of Minnesota and hemp breeding company Sunrise Genetics. The collaborators assembled a complete genome from a new cannabis variety and also examined several different cannabis varieties. They found that by breeding high-THC marijuana plants with
This story first appeared at Marijuana Business Daily. The development and extensive marketing of cosmetics containing cannabinoids—primarily CBD—has occurred in the absence of solid scientific evidence of their efficacy. Can cannabinoids even be absorbed into skin and, if so, can they have beneficial health effects? A recently published study suggests they can. Researchers in Poland
British American Tobacco is selling flavored CBD vapes in the United Kingdom as it eyes new products beyond tobacco and nicotine. But the parent company of Lucky Strike says it is not ready to enter the THC market yet. The company’s Chief Marketing Officer, Kingsley Wheaton, told CNBC this week that CBD is an “exciting
U.S. District Court for the Eastern District of New York Crediting the CBD company’s forthrightness, a federal judge in New York federal judge has dismissed a lawsuit against Massachusetts-based Curaleaf from investors who argued the company misled them about legality of its CBD products. The investors sued when Curaleaf’s share price fell in 2019 after
The National Football League and its players’ union have requested industry research on CBD and other cannabinoids for pain management. The NFL says it is looking for information about “alternatives to opioids in routine pain management.” The request mentions CBD but is open to research on other cannabinoids. The request issued Wednesday also mentions research
LONGMONT, COLO, February 17, 2021 — Hemp seed breeder Trilogene Seeds releases three new autoflower hemp varietals for 2021 seed sales, a bid to meet the needs of hemp growers in regions like Thailand and Latin America predicted to dominate the future of global CBD hemp production. After 80 years of prohibition, Thailand is the
SōRSE Technology, the leading water-soluble emulsion technology designed for infusing functional ingredients into consumer goods, announces the addition of 7.5% CBD liquid emulsion for personal care products to their product suite. SōRSE is designed for product developers to make oil-based functional ingredients water-soluble and more efficacious, while also providing the consumer with a consistent, safe
(Editor’s note: This story is part of a recurring series of commentaries from professionals connected to the hemp industry. Julie Lerner is CEO of PanXchange, a commodity trading platform and benchmark price provider.) Basing the multibillion-dollar, pie-in-the-sky forecasts for the U.S. addressable market for CBD on retail shelf prices disturbs me. It’s as illogical as
(A version of this story originally appeared at Marijuana Business Daily and will be updated.) An Irish pharmaceutical firm, Jazz Pharmaceuticals, has agreed to purchase United Kingdom-based GW Pharmaceuticals, one of the largest medical cannabinoid companies in the world, for $7.2 billion, the drug companies said Wednesday. The proposed cash-and-stock deal would be the largest
Hemp businesses walk a fine line when describing the health benefits of their products: Make a claim without evidence or wording that misleads consumers, and soon the legal fees will pile up. The U.S. Food and Drug Administration has guidelines for acceptable claims to make on labels for dietary supplements – the closest fit for
A cosmetics executive has been tapped to take over California CBD manufacturer Papa & Barkley. Evelyn Wang replaces Adam Grossman as CEO. Grossman will lead the company’s board of directors. Wang comes from Milani Cosmetics. She was formerly an assistant vice president for L’Oreal Paris, and before that was Product Director for Neutrogena Cosmetics, part
U.S. drug regulators have withdrawn their proposal to regulate over-the-counter CBD, handing the industry another setback after years of delay from the Food and Drug Administration. The proposal in question appears to be on pause because of the changing administration. The delay was widely anticipated but still frustrating for CBD operators awaiting the rules. The
This story first appeared at Marijuana Business Daily International. United Kingdom-based GW Pharmaceuticals expects to report annual sales of approximately $526 million for the year ended Dec. 31, 2020, it said in a preview of its fourth quarter and full-year results. Fourth-quarter net sales will be approximately $148 million, based on preliminary unaudited financial information,
Molson Coors Beverage Co. says it has launched CBD drinks in Colorado through TRUSS CBD USA, its joint venture with HEXO Corp. The beverage line will be available in three flavors – Grapefruit Tarragon, Strawberry Hibiscus and Blueberry Lavender under the name, “Verywell,” Molson Coors and HEXO said Wednesday. The companies first partnered in 2018
Federal food and drug officials said Friday that they plan to fill in current CBD research gaps with “real world data” — but industry advocates are frustrated that regulators haven’t done enough to clear up the rules, which has caused supply-chain bottlenecks while leaving consumers to navigate an increasing field of unregulated products. An update
THC distililate oil is displayed at PharmaCann Polska’s EU-GMP certified subsidiary, known as NYSK, in North Macedonia. – Photo courtesy PharmaCann This story originally appeared at Marijuana Business Daily. A new study shows consumers are unable to identify cannabinoid levels in products they use. Further, 20% to 50% don’t know the THC:CBD ratio of the
A version of this story first appeared on Marijuana Business Daily. Consumer demand has been pushing the THC potency of herbal marijuana upward for decades — but that increased potency does not extend to CBD levels, a new study has found. The systematic review and meta-analysis of studies between 1970–2017 found levels of THC increased
House Agriculture Chairman Collin Peterson, a Minnesota Democrat and sponsor of a bill to require federal food and agriculture regulators to treat hemp-derived CBD as a dietary supplement, has lost his re-election bid. Peterson lost to Republican challenger Michelle Fischbach on Tuesday. He has represented rural western Minnesota since 1991; demographic changes made him among
Canadian health authorities say there’s strong demand for over-the-counter, low-THC cannabis such as CBD, and most people want to use it for pain and inflammation if the country were to establish a legal market. That’s the result of a recent Health Canada survey. The agency is considering new rules about the sale of CBD and
Online retail giant Amazon has launched a pilot program allowing the sale of select CBD ingestibles on its UK website. The company says “sellers participating in a limited, invite-only pilot” on the UK site are exempt from its sales ban on edible products containing CBD or other cannabinoids. “This pilot only applies to products listed
A German CBD extractor has secured funding of an undisclosed amount from an independent investor in Hamburg who valued the company at 5 million euros ($5.9 million). Signature Products GmbH did not disclose the size of the investment but said in a statement that the investor’s appraisal makes it the youngest cannabis startup with the
CBD vape manufacturers and retailers in Germany will face a marketing and regulatory minefield starting in January because of recent changes to the country’s tobacco law. Under legislation passed by the German Bundestag on July 2, non-nicotine e-cigarettes and refillable containers will be regulated the way that their nicotine counterparts are, and additional advertising restrictions
Khiron Life Sciences, a vertically intergrated Colombian cannabis company, has signed a deal to sell its CBD skincare products in the Hong Kong region later this year. Khiron signed the distribution agreement for its Kuida CBD skincare line with DNO Group, an Asia-Pacific distributor with a network of more than 50,000 retail and online channels
Swiss customs officials have returned approximately CHF 33 million ($36 million) to low-THC cannabis flower producers and sellers after a court said their products were unconstitutionally taxed as a tobacco substitute. CBD sellers in Switzerland had taken legal action to protest the 25% sales tax imposed on their goods as tobacco substitutes, according to a
A drug delivery and development company in California with ambitions of entering the CBD consumer products market has made a $20 million offer to buy a CBD beauty and pet product company. Oxnard-based CURE Pharmaceutical said Tuesday it had reached an agreement with Los Angeles-based Sera Labs to acquire 100% of the privately owned company